Guido Leoni

8PUBLICATIONS
41CO-AUTHORS
Molecular targetsInnate immunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 20, 2024
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer.

Elisa De Paolis, Camilla Nero, Elisa Micarelli

|Mar 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno

|Feb 08, 2024
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine.

Irene Garzia, Linda Nocchi, Lidia Avalle

|Dec 09, 2023
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer.

Laura Seclì, Guido Leoni, Valentino Ruzza

|Aug 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.

Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis

|Jan 05, 2021
Involvement of miR-190b in Xbp1 mRNA Splicing upon Tocotrienol Treatment.

Roberto Ambra, Sonia Manca, Guido Leoni

Pageof 2